DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Cines DB, Gernsheimer T, Wasser J. et al.
Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim.
Int J Hematol 2015;
102: 259-270.
We do not assume any responsibility for the contents of the web pages of other providers.